Officer Dennis Mulroy Files to Sell Another $1.1M in Stock, Continuing Recent Liquidation Trend
ANAB has more than doubled off its 52-week low of $11.402.
Summary
Officer Dennis Mulroy has filed a Form 144 indicating intent to sell an additional $1.12 million worth of common stock, extending a recent pattern of significant insider sales.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files to Sell Shares
Officer Dennis Mulroy has filed a Form 144 to sell 21,987 shares of common stock, valued at approximately $1.12 million.
-
Continuation of Selling Trend
This filing extends a pattern of significant insider selling by Dennis Mulroy, who has reported over $9.98 million in sales over the past three months.
-
Context of Corporate Actions
The ongoing insider sales occur after the company completed its biopharma spin-off and announced a $100 million share repurchase program in May.
Analysis · ANAB · Life Sciences
This Form 144 indicates an officer's intent to sell a significant block of shares, adding to a consistent pattern of insider selling by Dennis Mulroy over the past three months. While the company recently completed a major spin-off and initiated a share repurchase program, the continued liquidation of shares by an officer could be interpreted as a lack of conviction in the company's near-term prospects or a need for personal liquidity, potentially offsetting some positive sentiment from the buyback.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ANAB was trading at $51.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.